Wang Li

2.6k total citations
108 papers, 2.0k citations indexed

About

Wang Li is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Wang Li has authored 108 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 30 papers in Cancer Research and 25 papers in Hepatology. Recurrent topics in Wang Li's work include Hepatocellular Carcinoma Treatment and Prognosis (21 papers), RNA modifications and cancer (17 papers) and Cancer-related molecular mechanisms research (17 papers). Wang Li is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (21 papers), RNA modifications and cancer (17 papers) and Cancer-related molecular mechanisms research (17 papers). Wang Li collaborates with scholars based in China, United States and Russia. Wang Li's co-authors include Peihong Wu, Qifeng Chen, Lujun Shen, Tao Huang, Ming Zhao, Zilin Huang, Lianying Guo, Chang-Chuan Pan, Boyang Chang and Ting Zhang and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Wang Li

106 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wang Li China	27	769	543	497	470	376	108	2.0k
Margret Rave‐Fränk Germany	25	732 1.0×	665 1.2×	395 0.8×	343 0.7×	125 0.3×	89	1.9k
Chia-Jui Yen Taiwan	28	1.1k 1.4×	955 1.8×	530 1.1×	613 1.3×	777 2.1×	63	2.7k
Zhan‐Hong Chen China	22	1.0k 1.4×	555 1.0×	261 0.5×	838 1.8×	227 0.6×	65	1.9k
Ramasamy Jagadeeswaran United States	22	1.1k 1.5×	601 1.1×	732 1.5×	238 0.5×	699 1.9×	47	2.3k
Yoshiyasu Nakamura Japan	25	650 0.8×	528 1.0×	398 0.8×	325 0.7×	161 0.4×	71	1.6k
Kyung Hwan Kim South Korea	26	429 0.6×	994 1.8×	485 1.0×	326 0.7×	120 0.3×	95	2.2k
Luca Faloppi Italy	25	580 0.8×	807 1.5×	499 1.0×	601 1.3×	457 1.2×	92	1.8k
Haiyong Wang China	27	867 1.1×	550 1.0×	370 0.7×	477 1.0×	144 0.4×	83	1.8k
Suimin Qiu United States	26	1.0k 1.3×	942 1.7×	234 0.5×	428 0.9×	110 0.3×	91	2.5k
Shaoyu Yan United States	25	910 1.2×	595 1.1×	421 0.8×	326 0.7×	166 0.4×	39	1.9k

Countries citing papers authored by Wang Li

Since Specialization

Citations

This map shows the geographic impact of Wang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Li more than expected).

Fields of papers citing papers by Wang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Li. The network helps show where Wang Li may publish in the future.

Co-authorship network of co-authors of Wang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wang Li. A scholar is included among the top collaborators of Wang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang Li. Wang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Ran, Mengxuan Zuo, Wang Li, et al.. (2025). Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization. Radiology Imaging Cancer. 7(5). e250034–e250034.

Yang, Yi, et al.. (2024). Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma. Hepatology International. 18(5). 1486–1498. 5 indexed citations

Hu, Zongqiang, Yingpeng Zhao, Jie Jiang, et al.. (2023). Exosome‐derived miR ‐142‐5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB. Environmental Toxicology. 38(8). 1860–1873. 9 indexed citations

An, Chao, Yan Fu, Wang Li, Mengxuan Zuo, & Peihong Wu. (2023). Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy. Cancer. 129(14). 2235–2244. 13 indexed citations

Wang, Hongfei, et al.. (2022). Changes in serum lncrna meg3/mir-181b and uch-l1 levels in patients with moderate and severe intracerebral hemorrhage. Turkish Neurosurgery. 34(1). 20–27. 4 indexed citations

Tang, Min, et al.. (2016). Research progress in immunotherapy of the triple-negative breast cancer. Immunological Journal. 177–180. 1 indexed citations

Li, Wang. (2011). Correlation of excision repair cross-complementing group 2 polymorphisms and response to platinum-based chemotherapy in advanced non-small cell lung cancer. Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhi. 2 indexed citations

Butler, Mary Ann, Lynn T. Frame, Berrin Serdar, et al.. (2011). The utility of naphthyl-keratin adducts as biomarkers for jet-fuel exposure. Biomarkers. 16(7). 590–599. 4 indexed citations

Pan, Chang-Chuan, et al.. (2010). Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy. Chinese Journal of Cancer. 29(6). 596–602. 36 indexed citations

10.

Chen, Hai-Bin, Mianhua Wu, Ruiping Wang, et al.. (2010). Clinical observation of Xiao'ai Jiedu Prescription combined with chemotherapy on advanced cancer. Zhonghua zhongyiyao zazhi. 25(7). 1140–1143. 3 indexed citations

11.

Yang, Xiaoli, Jingyun Li, Liping Zhang, et al.. (2010). Characterization of HIV antibody indeterminate status and impact factors on HIV tests.. Zhongguo yiyuan ganranxue zazhi. 20(13). 1844–1846. 1 indexed citations

12.

Li, Wang. (2009). Association Study of the Disrupted in Schizophrenia 1(DISC1)Gene Polymorphisms with Schizophrenia. Zhongguo xinli weisheng zazhi. 3 indexed citations

13.

Zheng, Junnian, Dong‐Sheng Pei, Baofu Zhang, et al.. (2009). Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene. Cancer Biology & Therapy. 8(1). 84–91. 26 indexed citations

14.

Li, Wang. (2009). Interventional effects of natural or chemosynthesis statin on serum NO,ET,hs-CRP,IL-1 and TNF-α in simple essential hypertensive patients. Di-san junyi daxue xuebao. 1 indexed citations

15.

Xia, Xiaojuan, et al.. (2008). The optimization of RAPD-PCR system with orthogonal design and primers screening in Platycodon grandiflorum. Xibei Nong-Lin Keji Daxue xuebao. Ziran kexue ban. 1 indexed citations

16.

Wang, Xingbing, Yuling He, Feng Yu, et al.. (2007). CCL19 and CXCL13 Synergistically Regulate Interaction between B Cell Acute Lymphocytic Leukemia CD23+CD5+ B Cells and CD8+ T Cells. The Journal of Immunology. 179(5). 2880–2888. 15 indexed citations

17.

Li, Wang, et al.. (2004). The Function of Ca~(2+) in Mammal Cells and the Relationship between Ca~(2+) and Disease. 10(1). 89–93. 1 indexed citations

18.

Li, Wang. (2003). Metabolic Abnormality of Triglyceride-Rich Lipoproteins and Atherosclerosis. 1 indexed citations

19.

Li, Wang. (1999). The Pharmacology Activities and the Clinical Applied in the Water Soluble Coronet Composition. 2 indexed citations

20.

Li, Wang. (1995). Effect of d1-praeruptorin A on delayed outward potassium current in single ventricular cell of guinea pig. Zhongguo yaolixue yu dulixue zazhi. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact